Why we lose interest in sex: Do neurosteroids play a role?

Sexuality, Reproduction and Menopause

Volumn 4, Issue 1, 2006, Pages 20-23

  King, Steven R ^a   Lamb, Dolores J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA DIHYDROPROGESTERONE; 5ALPHA PREGNANE 3,20 DIONE; ANDROGEN; ANDROGEN RECEPTOR; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; ESTROGEN RECEPTOR; GANAXOLONE; NARCOTIC AGENT; NEUROSTEROID; PRASTERONE; PREGNENOLONE SULFATE; PROGESTERONE RECEPTOR; STEROID; TESTOSTERONE;

ACNE; ALOPECIA; BREAST CANCER; CARDIOVASCULAR DISEASE; CATAMENIAL EPILEPSY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG EFFICACY; DRUG SAFETY; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE ACTION; HORMONE DETERMINATION; HORMONE INHIBITION; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; LACTATION DISORDER; LARYNX DISORDER; LIBIDO; LIBIDO DISORDER; LIVER TOXICITY; LOW DRUG DOSE; MALE SEXUAL DYSFUNCTION; NERVE CELL STIMULATION; NEUROMODULATION; NONHUMAN; PATIENT COUNSELING; POLYCYTHEMIA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; SLEEP APNEA SYNDROME; SPERMATOZOON COUNT; TESTIS ATROPHY; VASCULAR DISEASE; WEIGHT GAIN;

EID: 33645943086     PISSN: 15462501     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sram.2006.03.007     Document Type: Review

References (22)

1. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 186 (2005) 411-427
2. Dominguez J., and Hull E. Dopamine, the medial preoptic area, and male sexual behavior. Physiol Behav 86 (2005) 356-368
3. Tenover J. Experience with testosterone replacement in the elderly. Mayo Clin Proc 75 Suppl (2000) S77-S82
4. McGinnis M., Marcelli M., and Lamb D. Consequences of mutations in androgen receptor genes: molecular biology and behavior. In: Pfaff D. (Ed). Hormones, Brain and Behavior (2002), Academic Press, London 347-379
5. Sarrel P. Sexual dysfunction: treat or refer. Obstet Gynecol 106 (2005) 834-839
6. Steinberger E., and Smith K. Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: a preliminary evaluation of a possible male contraceptive. Fertil Steril 28 (1977) 1320-1328
7. Wang C., and Swerdloff R. Male hormonal contraception. Am J Obstet Gynecol 190 (2004) S60-S68
8. Swerdloff R., and Wang C. Androgens and the aging male. Best Pract Res Clin Endocrinol Metab 18 (2004) 349-362
9. Davis S., and Burger H. The role of androgen therapy. Best Pract Res Clin Endocrinol Metab 17 (2003) 165-175
10. Avis N., Zhao X., Johannes C., Ory M., Brockwell S., and Greendale G. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause 12 (2005) 385-398
11. Corpechot C., Robel P., Axelson M., Sjovall J., and Baulieu E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78 (1981) 4704-4707
12. Compagnone N., Bulfone A., Rubenstein J., and Mellon S. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology 136 (1995) 2689-2696
13. King S., Manna P., Ishii T., et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci 22 (2002) 10613-10620
14. Strous R., Maayan R., and Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol 16 (2006) 155-230
15. King S., Ginsberg S., Ishii T., Smith R., Parker K., and Lamb D. The steroidogenic acute regulatory protein is expressed in steroidogenic cells of the day-old brain. Endocrinology 145 (2004) 4775-4780
16. Genazzani A., Palumbo M., de Micheroux A., et al. Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. Eur J Endocrinol 133 (1995) 375-380
17. Petralia S., Jahagirdar V., and Frye C. Inhibiting biosynthesis and/or metabolism of progestins in the ventral tegmental area attenuates lordosis of rats in behavioural oestrus. J Neuroendocrinol 17 (2005) 545-552
18. Calogero A., Palumbo M., Bosboom A., et al. The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the α-aminobutyric acid A receptor. J Endocrinol 158 (1998) 121-125
19. Frye C. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res Brain Res Rev 37 (2001) 201-222
20. Kavaliers M., Wiebe J., and Galea L. Male preference for the odors of estrous female mice is enhanced by the neurosteroid 3α-hydroxy-4-pregnen-20-one (3αHP). Brain Res 646 (1994) 140-144
21. Kavaliers M., and Kinsella D. Male preference for the odors of estrous female mice is reduced by the neurosteroid pregnenolone sulfate. Brain Res 682 (1995) 222-226
22. Cross E., and Roselli C. 17α-Estradiol rapidly facilitates chemoinvestigation and mounting in castrated male rats. Am J Physiol 276 (1999) R1346-R1350